American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Association.
2.
Barnard-BrakL.SulakT.FearonD. (2011). Coexisting disorders and academic achievement among children with ADHD. Journal of Attention Disorders, 15(6), 506-515.
3.
BoboN.AdamsV.CooperL. (2002). Excellence in school nursing practice: Developing a national perspective on school nursing competencies. Journal of School Nursing, 18(5), 277-285.
4.
DangM.WarringtonD.TungT.BakerD.PanR. (2007). A school-based approach to early identification and management of students with ADHD. Journal of School Nursing23(1), 2-12.
5.
LallyM.KralM.BoanA. (2015). Not all generic Concerta is created equal: Comparison of OROS versus non-OROS for the treatment of ADHD. Clinical Pediatrics. Advance online publication. PMID:2646756
6.
McClanahanR.WeismullerP. (2015). School nurses and care coordination for children with complex needs: An integrative review. Journal of School Nursing, 31(1), 34-43.
National Association of School Nurses. (2016). Framework for 21st century school nursing practice. NASN School Nurse, 31(1), 45-53. doi:10.1177/1942602X15618644
PlattL. (2014). Identifying students at risk for mental health problems. NASN School Nurse, 29(6), 299-302. doi:10.1177/1942602X14550402
11.
StahlS. (2014). Stahl’s essential psychopharmacology: Prescriber’s guide (5th ed.). New York, NY: Cambridge University Press.
12.
StevensJ.WilensT.SternT. (2013). Using stimulants for attention-deficit/hyperactivity disorder: Clinical approaches and challenges. Primary Care Companion CNS Disorders, 15(2). PMID:PMC3733520
13.
U.S. Food and Drug Administration. (2014). Methylphenidate hydrochloride extended release tablets (generic Concerta) made by Mallinckrodt and Kudco. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm422568.htm
